Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment
Hailing Tang, Pan Yonghong, Zhang Yu-feng, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 592-605
Closed Access | Times Cited: 24

Showing 24 citing articles:

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 19
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer
Qiang Zhang, Kaisa Cui, Yue Kong, et al.
Cell Reports (2025) Vol. 44, Iss. 3, pp. 115327-115327
Open Access | Times Cited: 1
Recent advances in peptide-based therapeutic strategies for breast cancer treatment
Ling Li, Gregory J. Duns, Wubliker Dessie, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Three Strategies in Engineering Nanomedicines for Tumor Microenvironment‐Enabled Phototherapy
Shiliang He, Xiao Jia, Sai Feng, et al.
Small (2023) Vol. 19, Iss. 37
Closed Access | Times Cited: 18
Peptide-based non-viral gene delivery: A comprehensive review of the advances and challenges
Kai Xiang, Yanan Li, Hailin Cong, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131194-131194
Closed Access | Times Cited: 6
Emerging paradigms and recent progress in targeting ErbB in cancers
Nicolas Stoup, Maxime Liberelle, Nicolas Lebègue, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 552-576
Open Access | Times Cited: 5
Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Hailing Tang, Lijuan Li, Baoshan Wang
AAPS Open (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Poly(phenylalanine) and poly(3,4-dihydroxy-L-phenylalanine): Promising biomedical materials for building stimuli-responsive nanocarriers
Lingcong Zeng, Dandan Kang, Linglin Zhu, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 810-828
Closed Access | Times Cited: 4
Targeted Delivery of SmacN7 Peptide Induces Immunogenic Cell Death in Cervical Cancer Treatment
Yan Dai, Shentao Lu, Linna Wei, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
Self-assembly GSH response based peptide-drug nanocombination synergistically promotes DNA damage for prostate cancer immunotherapy
Maosong Hu, Yuyu Zhu, Xinyi Tang, et al.
Chemical Engineering Journal (2025), pp. 160862-160862
Closed Access
Supramolecular self-assembly of multifunctional carrageenan-based Nanomicelles for effective tumor therapy via apoptosis and immunogenic cell death
Xiangyan Chen, Guohua Ma, Junyao Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141518-141518
Closed Access
Weakened serum albumin binding-to-activated EGFR internalization in cellular accumulation for the synergistic toxicity of tetrabromobisphenol A and perfluorooctanoic acid
Chuxuan Chen, Xi‐Juan Chao, Mingjiang Zuo, et al.
Environmental Chemistry and Ecotoxicology (2025)
Open Access
Radiocobalt-Labeling of a Polypyridylamine Chelate Conjugated to GE11 for EGFR-Targeted Theranostics
Lorraine Gaenaelle Gé, Mathias Bogetoft Danielsen, Aaraby Nielsen, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 212-212
Open Access
Sphingosine kinase 2 in cancer: A review of its expression, function, and inhibitor development
Yanqun Luo, Haiping Xue, Ying Gao, et al.
International Journal of Biological Macromolecules (2025), pp. 141392-141392
Closed Access
Catalyst-free thiazolidine formation chemistry enables the facile construction of peptide/protein–cell conjugates (PCCs) at physiological pH
Xiangquan Liu, Youyu Wang, Bang‐Ce Ye, et al.
Chemical Science (2023) Vol. 14, Iss. 26, pp. 7334-7345
Open Access | Times Cited: 7
Gemcitabine–Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice
Prakash Shrestha, Yashwardhan Ghanwatkar, Sohan Mahto, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 23, pp. 29686-29698
Open Access | Times Cited: 2
EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics
Cibele Rodrigues Toledo, Ahmed A. Tantawy, Leonardo Lima Fuscaldi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8553-8553
Open Access | Times Cited: 2
Near-infrared-responsive GE11-CuS@Gal nanoparticles as an intelligent drug release system for targeting therapy against oral squamous cell carcinoma
Qing-Hua Lan, Shuanghu Wang, Zhouming Chen, et al.
International Journal of Pharmaceutics (2023) Vol. 649, pp. 123667-123667
Open Access | Times Cited: 6
Development of light and pH-dual responsive self-quenching theranostic SPION to make EGFR overexpressing micro tumors glow and destroy
Nihan Verimli, S. İrem Goralı, Beyza Abisoglu, et al.
Journal of Photochemistry and Photobiology B Biology (2023) Vol. 248, pp. 112797-112797
Closed Access | Times Cited: 5
Nucleolin promotes tumor growth in colorectal cancer by enhancing hnRNPA1-mediated PKM2 alternative splicing
Xue Wang, Han Cheng, Die Hu, et al.
Genes & Diseases (2023) Vol. 10, Iss. 6, pp. 2237-2240
Open Access | Times Cited: 4
EGF‐driven EGFR/miR‐27b‐3p/FOXO1 promotes rat FSH synthesis and secretion
Yi‐Ran Ma, Wei Gao, Hao‐Qi Wang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 4
Closed Access
Ultrasound‐Responsive Lipid Nanoparticles for Targeted Therapy and Controlled Drug Release in Non‐Small Cell Lung Cancer
Min Woo Kim, Sol Moon, Yong Il Park, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 12
Closed Access
Page 1

Scroll to top